mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |